Handelsbanken Fonder Ab Alnylam Pharmaceuticals, Inc. Transaction History

Handelsbanken Fonder Ab

$24.3 Billion
Q1 2025

A detailed history of Handelsbanken Fonder Ab transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 116,683 shares of ALNY stock, worth $51.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

116,683

Previous 54,346 114.7%

Holding current value

$51.2 Million

Previous $12.8 Million 146.38%

% of portfolio

0.13%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$233.07 - $290.7 $14.5 Million - $18.1 Million	62,337 Added 114.7%	116,683 $31.5 Million
Q4 2024 Feb 03, 2025	SELL	$232.27 - $300.43 $4.37 Million - $5.66 Million	-18,835 Reduced 25.74%	54,346 $12.8 Million
Q3 2024 Oct 04, 2024	BUY	$233.81 - $287.01 $30,395 - $37,311	130 Added 0.18%	73,181 $20.1 Million
Q2 2024 Aug 05, 2024	SELL	$143.31 - $247.0 $294,502 - $507,585	-2,055 Reduced 2.74%	73,051 $17.8 Million
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $30,474 - $41,225	208 Added 0.28%	75,106 $11.2 Million
Q4 2023 Feb 01, 2024	SELL	$151.41 - $196.57 $14.4 Million - $18.6 Million	-94,845 Reduced 55.88%	74,898 $14.3 Million
Q3 2023 Oct 19, 2023	BUY	$170.77 - $211.65 $16,906 - $20,953	99 Added 0.06%	169,743 $30.1 Million
Q2 2023 Aug 02, 2023	SELL	$185.01 - $212.05 $304,341 - $348,822	-1,645 Reduced 0.96%	169,644 $32.2 Million
Q1 2023 Apr 28, 2023	SELL	$182.66 - $235.53 $3.84 Million - $4.95 Million	-21,005 Reduced 10.92%	171,289 $34.3 Million
Q4 2022 Feb 07, 2023	BUY	$185.53 - $241.31 $12 Million - $15.6 Million	64,701 Added 50.71%	192,294 $45.7 Million
Q3 2022 Oct 27, 2022	SELL	$138.54 - $232.0 $6.15 Million - $10.3 Million	-44,407 Reduced 25.82%	127,593 $25.5 Million
Q2 2022 Aug 03, 2022	BUY	$120.42 - $169.29 $72,252 - $101,574	600 Added 0.35%	172,000 $25.1 Million
Q1 2022 May 11, 2022	SELL	$127.18 - $173.91 $2.09 Million - $2.85 Million	-16,400 Reduced 8.73%	171,400 $28 Million
Q4 2021 Feb 08, 2022	BUY	$159.56 - $209.29 $26.8 Million - $35.1 Million	167,700 Added 834.33%	187,800 $31.8 Million
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $169,750 - $207,730	1,000 Added 5.24%	20,100 $3.8 Million
Q2 2021 Aug 03, 2021	SELL	$128.63 - $176.89 $154,356 - $212,267	-1,200 Reduced 5.91%	19,100 $3.24 Million
Q1 2021 Apr 29, 2021	SELL	$126.83 - $175.69 $177,562 - $245,966	-1,400 Reduced 6.45%	20,300 $2.87 Million
Q4 2020 Feb 11, 2021	BUY	$122.97 - $147.0 $307,425 - $367,500	2,500 Added 13.02%	21,700 $2.82 Million
Q2 2020 Aug 13, 2020	BUY	$104.21 - $156.44 $2 Million - $3 Million	19,200 New	19,200 $2.84 Million

Others Institutions Holding ALNY

# of Institutions

746

Shares Held

110M

Call Options Held

966K

Put Options Held

841K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $54B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Alnylam Pharmaceuticals, Inc. Transaction History